Cart
sales@molnova.com
[SER140]-PLP(139-151)
CAS No. 122018-58-0
[SER140]-PLP(139-151)( —— )
Catalog No. M30011 CAS No. 122018-58-0
[SER140]-PLP(139-151) is a polypeptide fragment of the lipid protein of myelin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 437 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product Name[SER140]-PLP(139-151)
-
NoteResearch use only, not for human use.
-
Brief Description[SER140]-PLP(139-151) is a polypeptide fragment of the lipid protein of myelin.
-
Description[SER140]-PLP(139-151) is a polypeptide fragment of the lipid protein of myelin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number122018-58-0
-
Formula Weight1521.72
-
Molecular FormulaC72H104N20O17
-
Purity>98% (HPLC)
-
SolubilityH2O : ≥ 11.11 mg/mL (7.30 mM)
-
SMILES——
-
Chemical NameSequence:His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Kordopati GG, et al. Biologically relevant conformational features of linear and cyclic proteolipid protein (PLP) peptide analogues obtained by high-resolution nuclear magnetic resonance and molecular dynamics. J Comput Aided Mol Des. 2017 Jul 29.
molnova catalog
related products
-
MPO-IN-28
MPO-IN-28 is a novel potent irreversible Myeloperoxidase (MPO) inhibitor with IC50 of 44 nM.
-
NFAT Inhibitor
NFAT inhibitor is a cell-permeable compound that selectively inhibits calcineurin-mediated dephosphorylation of NFAT.
-
iCRT 14
iCRT 14 is a novel potent inhibitor of β-catenin-responsive transcription (CRT)(IC50= 40.3 nM in assays of Wnt pathway activity).
